Literature DB >> 2080911

The cellular and molecular events of central nervous system remyelination.

M Dubois-Dalcq1, R Armstrong.   

Abstract

Central nervous system (CNS)* regeneration is a subject of great interest, particularly in diseases causing a dramatic loss of neurons. However, some CNS diseases do not affect neurons but damage other cells, such as the myelin-forming cells--called oligodendrocytes--which are also crucial to the harmonious function of the nervous system. Diseases in which oligodendrocytes and myelin are attacked can cause devastating neurological dysfunction which is sometimes followed by recovery and myelin repair or remyelination. The question of the regeneration potential of oligodendrocytes in experimental and human demyelinating diseases such as multiple sclerosis has been debated for a long time. Present evidence suggests that oligodendrocyte precursor cells persist in the adult CNS and that oligodendrocyte regeneration can occur but may be limited by ongoing disease processes. Here we will briefly review recent advances which have broadened our understanding of the cellular and molecular events of CNS remyelination.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2080911     DOI: 10.1002/bies.950121203

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  11 in total

Review 1.  From stem cells to oligodendrocytes: prospects for brain therapy.

Authors:  Cui P Chen; Mary E Kiel; Dorota Sadowski; Randall D McKinnon
Journal:  Stem Cell Rev       Date:  2007-12       Impact factor: 5.739

Review 2.  Do oligodendrocytes divide?

Authors:  W T Norton
Journal:  Neurochem Res       Date:  1996-04       Impact factor: 3.996

3.  Purification and characterization of adult oligodendrocyte precursor cells from the rat optic nerve.

Authors:  J Shi; A Marinovich; B A Barres
Journal:  J Neurosci       Date:  1998-06-15       Impact factor: 6.167

Review 4.  Macrophages in CNS remyelination: friend or foe?

Authors:  L T Diemel; C A Copelman; M L Cuzner
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

Review 5.  Current Challenges in Diabetic Retinopathy: Are We Really Doing Better?

Authors:  Jae Hyuck Lee; Su Jeong Song
Journal:  Endocrinol Metab (Seoul)       Date:  2016-06-10

Review 6.  Insights into the immunopathogenesis of multiple sclerosis.

Authors:  Niels Hellings; Jef Raus; Piet Stinissen
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

7.  Polysialylated neural cell adhesion molecule-positive CNS precursors generate both oligodendrocytes and Schwann cells to remyelinate the CNS after transplantation.

Authors:  H S Keirstead; T Ben-Hur; B Rogister; M T O'Leary; M Dubois-Dalcq; W F Blakemore
Journal:  J Neurosci       Date:  1999-09-01       Impact factor: 6.167

Review 8.  Oligodendroglial response to the immune cytokine interferon gamma.

Authors:  B Popko; K D Baerwald
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

9.  Transplantation of an oligodendrocyte cell line leading to extensive myelination.

Authors:  U Tontsch; D R Archer; M Dubois-Dalcq; I D Duncan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

10.  AMP-activated protein kinase signaling protects oligodendrocytes that restore central nervous system functions in an experimental autoimmune encephalomyelitis model.

Authors:  Ajaib S Paintlia; Manjeet K Paintlia; Sarumathi Mohan; Avtar K Singh; Inderjit Singh
Journal:  Am J Pathol       Date:  2013-06-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.